Amyloid Deposits in the Bone Marrow of Patients with Immunoglobulin Light Chain Amyloidosis Do Not Impact Stem Cell Mobilization or Engraftment

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 12, 2012, Pages 1935-1938

  Cowan, Andrew J ^a   Seldin, David C ^a,b   Skinner, Martha ^a   Quillen, Karen ^b,c   Doros, Gheorghe ^a,c   Tan, Josenia ^c   O'Hara, Carl ^a,c   Finn, Kathleen T ^a,b   Sanchorawala, Vaishali ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Melphalan; Stem cell collection; Stem cell transplantation

Indexed keywords

AMYLOID; CONGO RED; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN LIGHT CHAIN; MELPHALAN;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CLONAL VARIATION; CONTROLLED STUDY; DRUG MEGADOSE; ENGRAFTMENT; FEMALE; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; RETROSPECTIVE STUDY; STEM CELL MOBILIZATION; THROMBOCYTE COUNT; VASCULAR AMYLOIDOSIS;

ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; BONE MARROW; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MALE; MELPHALAN; MIDDLE AGED; MYELOABLATIVE AGONISTS; PLAQUE, AMYLOID; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION;

EID: 84869082433     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.07.016     Document Type: Article

References (9)

1. Cibeira M.T., Sanchorawala V., Seldin D.C., et al. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood 2011, 118:4346-4352.
2. Skinner M., Sanchorawala V., Seldin D.C., et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 2004, 140:85-93.
3. Pottinger B., Walker M., Campbell M., et al. The storage and re-infusion of autologous blood and BM as back-up following failed primary hematopoietic stem-cell transplantation: a survey of European practice. Cytotherapy 2002, 4:127-135.
4. + cells reinfused is the only factor predicting both granulocyte and platelet recovery. J Hematother 1996, 5:663-670.
5. Haas R., Mohle R., Fruhauf S., et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994, 83:3787-3794.
6. Tricot G., Jagannath S., Vesole D., et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995, 85:588-596.
7. Dreger P., Kloss M., Petersen B., et al. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995, 86:3970-3978.
8. Oran B., Malek K., Sanchorawala V., et al. Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis. Bone Marrow Transplant 2005, 35:567-575.
9. Swan N., Skinner M., O'Hara C.J. Bone marrow core biopsy specimens in AL (primary) amyloidosis. A morphologic and immunohistochemical study of 100 cases. Am J Clin Pathol 2003, 120:610-616.